Recombinant Human Annexin A5 Ameliorates Localized Scleroderma by Inhibiting the Activation of Fibroblasts and Macrophages

    July 2025 in “ Pharmaceutics
    Bijun Kang, Zhuoxuan Jia, Wei Li, Wenjie Zhang
    TLDR Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.
    The study demonstrates that recombinant human Annexin A5 (AnxA5) has significant anti-fibrotic and anti-inflammatory effects in treating localized scleroderma (LoS). AnxA5 inhibits the TGF-β/Smad2 signaling pathway in dermal fibroblasts, reducing collagen synthesis and secretion, and modulates macrophage activity to decrease inflammation. In murine models, both systemic and topical applications of AnxA5 effectively reduced fibrosis and inflammation, with preventative treatment showing superior efficacy. These findings suggest AnxA5 as a promising therapeutic candidate for LoS and potentially other fibrotic skin diseases, with ongoing research needed to optimize delivery methods and dosage.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 10 results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community The theory that explains everything. Please help me make this big!

      in Research/Science  2445 upvotes 4 years ago
      The post and conversation are about the role of the enzyme 3alpha-hydroxysteroid reductase in hair loss and the potential of compounds like procyanidin B2 and sulforaphane to boost its activity for hair regrowth. Further research is needed to develop effective treatments based on this theory.

      community Serum based on plant extracts boosts hair growth in weeks.

      in Treatment  45 upvotes 2 months ago
      A serum containing Centella asiatica extracellular vesicles, IGF-1, FGF-7, and caffeine significantly improved hair thickness, density, length, and reduced hair loss after 56 days. The conversation also discusses how treatments like finasteride, minoxidil, and ketoconazole address different aspects of hair loss by reducing DHT, improving blood flow, and lowering inflammation.

    Similar Research

    5 / 1000+ results